Comorbidities role on death in diabetic patients with COVID-19 

Purpose: According to the possible role of other comorbidities in increase the risk of mortality in diabetes patient, recent study was designed to manage complications and mortality rate in this group of patients. Methods: : In this cross-sectional study (25 February to 10 July 2020) total of 458 diabetic patients were enrolled based on their characteristics, symptoms and signs, and presence of underlying diseases. Multiple logistic regression and χ2 test analysis used to check the effectiveness of comorbidities on the mortality outcome among diabetic patients. Results: : Of 458 diabetic patients, 306 (67%) were with underlying diseases (200 (65.4%) hypertension, 103 (33.7%) cardiovascular diseases and 29 (9.5%) kidney diseases). The rate of fatality was significantly high in patients with chronic kidney and liver diseases. The odds of mortality outcome increase 3.1 fold for patients over 55 years as compared to under 55 years (P =0.011), and the odds of mortality outcome was more than 5.1 folds for those who had chronic kidney disease (P <0.001). Conclusions: : The presentation of SARS-CoV-2 in older diabetic patients with comorbidities (chronic kidney and liver diseases) is more severe in risk of mortality.